Crockett Thomas Andrew - Insider Non-Derivative Transactions at KalVista Pharmaceuticals, Inc. (KALV) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Feb 20, 2024, Crockett Thomas Andrew's relationship to KalVista Pharmaceuticals, Inc. (KALV) is Director,Officer (CEO), and currently has 211,203 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other KALV insiders.

Data Source: SEC.
Crockett Thomas Andrew - Insider Non-Derivative Transactions of KALV Common Stock
Crockett Thomas Andrew - Insider Non-Derivative Transactions at KALV
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Feb 21, 2024 Sell -- (Common Stock) 24888 14.11 211203
Feb 18, 2024 M -- (Common Stock) 54415 0 236091
Feb 15, 2024 Sell -- (Common Stock) 58356 15.01 181676
Feb 12, 2024 Acquisition -- (Common Stock) 122500 0 240032
Feb 2, 2024 Sell -- (Common Stock) 700 16.81 117532
Feb 2, 2024 Sell -- (Common Stock) 9300 16.18 118232
Dec 28, 2023 Sell -- (Common Stock) 30000 12.02 127532
Nov 21, 2023 Sell -- (Common Stock) 14807 8.23 157532
Nov 18, 2023 M -- (Common Stock) 33583 0 172339
Oct 31, 2023 G -- (Common Stock) 8000 0 138756
Aug 19, 2023 Sell -- (Common Stock) 14876 10.73 146756
Aug 18, 2023 M -- (Common Stock) 33582 0 161632
May 19, 2023 Sell -- (Common Stock) 5627 10.14 128050
May 18, 2023 M -- (Common Stock) 12750 0 133677
Feb 18, 2023 Sell -- (Common Stock) 6700 7.66 120927
Feb 18, 2023 M -- (Common Stock) 12749 0 127627